For the treatment of type 2 diabetes, Prandin (the generic name is repaglinide) was approved by the US FDA in 1997, as the first in a new class of diabetes drugs that are commonly prescribed today. As an antidiabetic, Prandin helps the pancreas by stimulating the release of insulin. It only works when the pancreas gland is capable of making and releasing at least some insulin, and therefore, does not work for type 1 diabetes.

Learn about Possible Prandin Side Effects and Warnings

Even if someone does have type 2 diabetes, Prandin should not be used if they have severe problems such as diabetic ketoacidosis or diabetic coma, or if they’ve been prescribed gemfibrozil for high cholesterol. There are other medical conditions that may cause a reaction with Prandin. Anyone considering this drug for treatment should inform their doctor if they are pregnant or are breast-feeding, have any …